Literature DB >> 15542502

Increased gut permeability in Crohn's disease: is TNF the link?

P R Gibson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15542502      PMCID： PMC1774337          DOI： 10.1136/gut.2004.047092

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  23 in total

1.  Intestinal permeability in Crohn's disease patients and their first degree relatives.

Authors:  M Secondulfo; L de Magistris; R Fiandra; L Caserta; M Belletta; M T Tartaglione; G Riegler; F Biagi; G R Corazza; R Carratù
Journal:  Dig Liver Dis       Date:  2001-11       Impact factor: 4.088

2.  Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.

Authors:  Matthias Bruewer; Andreas Luegering; Torsten Kucharzik; Charles A Parkos; James L Madara; Ann M Hopkins; Asma Nusrat
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

3.  Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.

Authors:  N P Breslin; C Nash; R J Hilsden; N B Hershfield; L M Price; J B Meddings; L R Sutherland
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

4.  Apoptosis and intestinal barrier function.

Authors:  C Bojarski; K Bendfeldt; A H Gitter; J Mankertz; M Fromm; S Wagner; E O Riecken; J D Schulzke
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

Review 6.  Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?

Authors:  G-T Ho; F M Moodie; J Satsangi
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

7.  Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate.

Authors:  E C Clark; S D Patel; P R Chadwick; G Warhurst; A Curry; G L Carlson
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

8.  Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.

Authors:  Peter Suenaert; Veerle Bulteel; Liesbeth Lemmens; Maja Noman; Benny Geypens; Gert Van Assche; Karel Geboes; Jan L Ceuppens; Paul Rutgeerts
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

9.  Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?

Authors:  Bjarni Thjodleifsson; Gudmundur Sigthorsson; Nick Cariglia; Inga Reynisdottir; Daniel F Gudbjartsson; Kristleifur Kristjansson; Jonathan B Meddings; Vilmundur Gudnason; Johan H Wandall; Leif Percival Andersen; Roy Sherwood; Matthias Kjeld; Einar Oddsson; Hallgrimur Gudjonsson; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

10.  Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha.

Authors:  J D Söderholm; C Streutker; P-C Yang; C Paterson; P K Singh; D M McKay; P M Sherman; K Croitoru; M H Perdue
Journal:  Gut       Date:  2004-12       Impact factor: 23.059
View more
  59 in total

1.  Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model.

Authors:  Lily Nahidi; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2011-09-28       Impact factor: 7.527

2.  Segmental Differences in Radiation-Induced Alterations of Tight Junction-Related Proteins in Non-Human Primate Jejunum, Ileum and Colon.

Authors:  Sarita Garg; Junying Zheng; Junru Wang; Simon Authier; Mylene Pouliot; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2015-12-31       Impact factor: 2.841

Review 3.  Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.

Authors:  D S A Sanders
Journal:  J Clin Pathol       Date:  2005-06       Impact factor: 3.411

Review 4.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 5.  Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health.

Authors:  S Schreiber
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 6.  Role of the intestinal barrier in inflammatory bowel disease.

Authors:  Mike G Laukoetter; Porfirio Nava; Asma Nusrat
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

7.  Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats.

Authors:  Ana Paula Ribeiro Paiotti; Daniel Araki Ribeiro; Roseane Mendes Silva; Patrícia Marchi; Celina Tizuko Fujiyama Oshima; Ricardo Artigiani Neto; Sender Jankiel Miszputen; Marcello Franco
Journal:  J Mol Histol       Date:  2012-03-20       Impact factor: 2.611

8.  Tumour necrosis factor alpha contributes to protection against Giardia lamblia infection in mice.

Authors:  P Zhou; E Li; T Shea-Donohue; S M Singer
Journal:  Parasite Immunol       Date:  2007-07       Impact factor: 2.280

9.  Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation.

Authors:  Lily Nahidi; Steven T Leach; Daniel A Lemberg; Andrew S Day
Journal:  Dig Dis Sci       Date:  2013-09-19       Impact factor: 3.199

10.  1,25-Dihydroxyvitamin D Protects Intestinal Epithelial Barrier by Regulating the Myosin Light Chain Kinase Signaling Pathway.

Authors:  Jie Du; Yunzi Chen; Yongyan Shi; Tianjing Liu; Yong Cao; Yue Tang; Xin Ge; Hongguang Nie; Changqing Zheng; Yan Chun Li
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.